Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. - Wikidata - wikimedia - TriplyDB

Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction.

Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction.

http://www.wikidata.org/entity/Q37345172

about

Clinical decision making with myocardial perfusion imaging in patients with known or suspected coronary artery disease Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging The cardiac magnetic resonance (CMR) approach to assessing myocardial viability Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart Disease Cardiac Imaging in Heart Failure with Comorbidities.Noninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient: The Imaging Council of the American College of Cardiology Value of Exercise ECG for Risk Stratification in Suspected or Known CAD in the Era of Advanced Imaging Technologies Cardiovascular magnetic resonance imaging of myocardial infarction, viability, and cardiomyopathies.Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography.Diabetic cardiomyopathy: pathophysiology and clinical features What is the significance of unrecognized non-Q-wave myocardial infarction?Free-breathing, motion-corrected late gadolinium enhancement is robust and extends risk stratification to vulnerable patients.Prevalence and clinical relevance of the morphological substrate of ventricular arrhythmias in patients without known cardiac conditions detected by cardiovascular MR.Subclinical Myocardial Disease in Heart Failure Detected by CMR.Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults.Prevalence and prognosis of myocardial scar in patients with known or suspected coronary artery disease and normal wall motion.Non-contrast cardiac computed tomography can accurately detect chronic myocardial infarction: Validation study.Assessment of acute myocardial infarction: current status and recommendations from the North American society for Cardiovascular Imaging and the European Society of Cardiac Radiology Noninvasive assessment myocardial viability: current status and future directions.Assessment of myocardial fibrosis with cardiovascular magnetic resonance.Myocardial T1 mapping: techniques and potential applications.Cardiac autoimmunity as a novel biomarker, mediator, and therapeutic target of heart disease in type 1 diabetes.Clinical Significance of Late Enhancement and Regional Wall Remodeling Assessed by 3T Magnetic Resonance Imaging.Myocardial structure, function, and scar in patients with type 1 diabetes mellitus.Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy.Evaluation of Left Ventricle Function by Regional Fractional Area Change (RFAC) in a Mouse Model of Myocardial Infarction Secondary to Valsartan Treatment.Prevalence, Patterns, and Clinical Predictors of Left Ventricular Late Gadolinium Enhancement in Patients Undergoing Cardiac Magnetic Resonance Prior to Pulmonary Vein Antral Isolation for Atrial Fibrillation: A Cross-Sectional Observational Study Unrecognized myocardial infarctions assessed by cardiovascular magnetic resonance are associated with the severity of the stenosis in the supplying coronary artery.Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines.T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.Prevalence and Correlates of Myocardial Scar in a US Cohort Late gadolinium enhancement among survivors of sudden cardiac arrest Dobutamine stress cardiovascular magnetic resonance at 3 Tesla.Long-term prognosis of unrecognized myocardial infarction detected with cardiovascular magnetic resonance in an elderly population.Assessment of myocardial viability with delayed-enhancement MRI in coronary artery disease: A correlative study with coronary artery stenosis using digital subtraction angiography.Classic images in cardiac magnetic resonance imaging: a case-based atlas highlighting current applications of cardiac magnetic resonance imaging.Role of cardiac MRI in diabetes.Luteolin-7-diglucuronide attenuates isoproterenol-induced myocardial injury and fibrosis in mice Myocardial Infarct Size by CMR in Clinical Cardioprotection Studies: Insights From Randomized Controlled Trials

P2860

Q26859183-0B54978B-9986-44C3-A934-47C7FBA603A7 Q27003231-0496785A-B08C-4D97-ACF9-252A1E971A1C Q27014679-B9168AE0-D01D-4503-848C-2CC969CBAAC9 Q28066080-0DBDD8A9-79EB-4CDE-80F0-2E337B40FC63 Q30248624-F0C77350-D6E0-4639-84A9-B9A724C2576F Q30277401-E31AEA35-37C4-4F61-8BB8-5F223B731E37 Q30278097-4A149A89-DAB5-48E6-A4D4-9611BB84BB43 Q30432814-EA65CD16-32F7-44A0-892E-CE3DB6916BFF Q30456092-CF942741-6738-4D7E-8697-7D6F95367D13 Q30457504-3EBCCFD6-3AB1-4C30-B9DC-31B5720D20CE Q33432752-19C6C5C3-C154-49D1-8D2A-656D3495F000 Q33789865-A18B30D1-8957-4535-A068-1544974FD5DE Q33823185-A0393B33-E25D-43E8-8623-475542F62E48 Q34040150-7443FA1C-6966-43AB-9F10-CC070426A5F2 Q34065646-5DA1DC52-6E6A-49DD-90FB-6898861F3E29 Q34498658-8E063B8F-D6BD-4952-8BF8-BC8479605A89 Q34544821-1BBA2C8C-89FA-452E-8F7E-0CCB83862F85 Q34561285-2410ED0D-33BB-4F01-AA6C-15ABF0C9CF83 Q34774619-0D874E75-2872-4A70-A805-22B56065FDDB Q34846884-AD51E695-062C-4F8B-BCC3-B2FFA3A57FCC Q35174325-DE6CDC71-DF09-4CB0-B24A-AB5F3B0FCF23 Q35225450-A67368C9-1779-4F53-B5D8-238C4A00D525 Q35459309-E5426AB7-4B5C-4722-86BC-E2D8F6B81B34 Q35548457-2C28BE45-C44F-4C95-B866-71942A36DDA3 Q35549595-B9F12094-F2D5-4B0B-A5B0-984B02C5A1DF Q35751394-C4EA6753-3B2C-4B13-95D3-99639DEC8FE5 Q36256066-26F1B1E3-9874-43C8-8DFE-1600F2A62582 Q36301973-FD8854FA-220D-4C85-A5AA-7E337B709881 Q36395125-F000037C-C833-49CA-9E7A-9FC2C52CC46D Q36417705-1FDFCF1D-E7C1-49BC-9EC3-336FF97D9B8A Q36479405-4D335787-B710-4BBF-97C5-751F0B7A1257 Q36639587-D09A3591-5E19-413B-BF1A-D22CE79CB03D Q36672304-D09816DB-A13E-429B-96B5-43FB14A7B313 Q36946837-EF55AAA4-37DF-4609-BE5B-1A7FFA96AC3A Q37108148-8A05C4EE-E8DE-4221-BFC2-6AABA42BC95E Q37287520-361D2C4E-129D-4DB4-8C52-D59A6F52D846 Q37648304-FAFD2B24-B48A-4959-BBE9-AF7D453FFD60 Q37662894-59CC42B4-DC64-4852-AAC8-B40ABD52721A Q37688764-CD4711AF-9530-4630-8BC3-07A550C4685C Q37696752-1A943810-DAC4-4947-A5D7-4F9D97C7B5D9

P2860

Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction.

http://www.wikidata.org/entity/Q37345172

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Incidence and prognostic impli ...... ence of myocardial infarction.

@en

Incidence and prognostic impli ...... ence of myocardial infarction.

@nl

type

label

Incidence and prognostic impli ...... ence of myocardial infarction.

@en

Incidence and prognostic impli ...... ence of myocardial infarction.

@nl

prefLabel

Incidence and prognostic impli ...... ence of myocardial infarction.

@en

Incidence and prognostic impli ...... ence of myocardial infarction.

@nl

P1433

Q37345172-4C43CD9F-DF6A-479F-8A34-77108F81AAA5

P1476

Q37345172-862EC496-BC0E-41A9-A0CE-2A38FCBCE13C

P2093

Q37345172-05A2F599-FDBE-4520-BF2A-8A1A785E189B

Q37345172-45A33D09-BCEA-4743-A9E3-EE85014DC46F

Q37345172-64617FE0-F468-4F2F-8C31-EF3075E56DD8

Q37345172-8634A69B-59F0-4F46-AF32-4A25411DC600

Q37345172-A546D6DA-1F16-40E2-BB02-B7730AD8BFDE

Q37345172-A73BF8B2-EBF3-41E7-9B6F-8832CC67BF5F

Q37345172-ACADF687-B237-455F-AC5C-52C264DB7FA1

Q37345172-C701209E-813F-4375-816D-CA7E1A0B3550

P2860

Q37345172-0796D1DF-33D5-423B-BA06-3CB02453B6D0

Q37345172-09124238-D369-436C-86A6-DC7C4F28E078

Q37345172-1714B56E-4371-4DC9-9E62-236EF009A8D8

Q37345172-2231FDD1-CEF5-4ED9-BC6A-0B1D4B3C6F1D

Q37345172-552295AD-0065-422B-A304-6DD70B1D3CA8

Q37345172-5D352A7C-5F5C-41CE-9E6B-3D3F29F95E46

Q37345172-63B9933C-E3A7-483F-A8D7-BF6101EAC2BF

Q37345172-6446345E-3E36-4B77-AB0E-A8CA4A3D002B

Q37345172-7A6CF15A-D600-400D-8C82-88F839BDC950

Q37345172-7D297516-0B23-4967-8C9E-D48537E2A8DA

P304

Q37345172-4CA9E421-81C3-4546-9E76-67F888991DE5

P31

Q37345172-B0153277-F726-458A-B7C1-46CA86327585

P356

Q37345172-1F2851BA-3EE9-4FD3-ABC9-3274A2277148

P407

Q37345172-8554D79F-9476-4709-9565-62D9DBD9B386

P433

Q37345172-6D6E3A66-EFEC-40A8-9123-9B8B56CB6A53

P478

Q37345172-72F1CA48-F19F-4086-83FF-0D2556D57D1C

P577

Q37345172-BCE942CA-7298-4452-9768-46A7BB4D6558

P698

Q37345172-207C3B67-0260-4B61-9F44-BDC5C0D4D928

P921

Q37345172-261BA19B-34D9-4F57-87F3-94C84D4C83B8

Q37345172-DB42E477-4DC6-4B00-8EFC-766FCFFD2FAD

P932

Q37345172-D7F5B24A-57C6-4D8E-BA78-D326702F51A4

P356

CIRCULATIONAHA.107.727826

P1433

P1476

Incidence and prognostic impli ...... ence of myocardial infarction.

@en

P2093

Gabriel Vorobiof

http://www.w3.org/2001/XMLSchema#string

Hamid Sattar

http://www.w3.org/2001/XMLSchema#string

Henry Wu

http://www.w3.org/2001/XMLSchema#string

Kenneth A Brown

http://www.w3.org/2001/XMLSchema#string

Kevin Steel

http://www.w3.org/2001/XMLSchema#string

Raymond Y Kwong

http://www.w3.org/2001/XMLSchema#string

Samuel Siu

http://www.w3.org/2001/XMLSchema#string

Vijay Gandla

http://www.w3.org/2001/XMLSchema#string

P2860

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way.

Assessment of ventricular function and mass by cardiac magnetic resonance imaging.

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

Epidemiology of hypertension.

Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation.

Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography.

P304

1011-1020

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.107.727826

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18725488

http://www.w3.org/2001/XMLSchema#string

P921

P932

2743310

http://www.w3.org/2001/XMLSchema#string